(Press-News.org) Contact information: Stewart Cole
stewart.cole@epfl.ch
41-216-931-851
Ecole Polytechnique Fédérale de Lausanne
Tuberculosis: Nature has a double-duty antibiotic up her sleeve
A natural antibiotic turns out to be a lethal weapon in the fight against tuberculosis. Scientists have discovered it has an unexpected dual action that dramatically reduces the probability that TB bacteria will become resistant
Technology has made it possible to synthesize increasingly targeted drugs. But scientists still have much to learn from Mother Nature. Pyridomycin, a substance produced by non-pathogenic soil bacteria, has been found to be a potent antibiotic against a related strain of bacteria that cause tuberculosis. The EPFL scientists who discovered this unexpected property now have a better understanding of how the molecule functions. Its complex three-dimensional structure allows it to act simultaneously on two parts of a key enzyme in the tuberculosis bacillus, and in doing so, dramatically reduce the risk that the bacteria will develop multiple resistances. The researchers, along with their colleagues at ETH Zurich, have published their results in the journal Nature Chemical Biology.
Stewart Cole, director of EPFL's Global Health Institute, led a team that discovered the anti-tuberculosis effect of pyridomycin in 2012. By inhibiting the action of the "InhA" enzyme, pyridomycin literally caused the thick lipid membrane of the bacterium to burst. Now the scientists understand how the molecule does this job.
Dual anti-mutation ability
The tuberculosis bacillus needs the InhA enzyme along with what scientists refer to as a "co-factor," which activates the enzyme, in order to manufacture its membrane. The scientists discovered that pyridomycin binds with the co-factor, neutralizing it.
But pyridomycin doesn't stop there. It also blocks another element needed for making the membrane, the InhA binding site. "Researchers in the pharmaceutical industry have been looking for this weakness in the TB bacillus for decades," explains Ruben Hartkoorn, first author on the article.
By binding simultaneously onto these two elements and neutralizing them, pyridomycin prevents the bacterium from generating its membrane, and it ends up bursting like a balloon. Better still, this dual action drastically reduces the risk that the bacteria will become resistant, because in order to develop resistance, two different specific mutations must exist at the same time. This is increasingly important because cases of multi-resistant TB are on the rise.
Nature's twisting paths – a lesson in efficiency
"It's a powerful lesson from nature with respect to drug design," explains Cole, co-author and EPFL professor. "The three-dimensional structures of naturally occurring molecules are often more complex, more twisted, than synthetic molecules, and that's precisely what allows pyridomycin to bind onto these two sites simultaneously."
In fact, it binds so effectively that the molecule is not yet ready to be used therapeutically: it doesn't last long enough in the patient's body. This is the point at which bioengineering needs to take over from Mother Nature – to develop a more robust version of the molecule. This is what the ETH team led by Karl-Heinz Altmann is working on. "Eventually we could multiply the molecule's binding sites, so that it could inhibit critical functions of other pathogenic bacteria," says Cole.
### END
Tuberculosis: Nature has a double-duty antibiotic up her sleeve
A natural antibiotic turns out to be a lethal weapon in the fight against tuberculosis. Scientists have discovered it has an unexpected dual action that dramatically reduces the probability that TB bacteria will become resistant
2013-12-03
ELSE PRESS RELEASES FROM THIS DATE:
New research will allow more reliable dating of major past events
2013-12-03
New research will allow more reliable dating of major past events
Academics have developed a new internationally agreed radiocarbon calibration curve which will allow key past events to be dated more accurately
Academics have developed a new method ...
LSTM researchers among first to sequence snake genome
2013-12-03
LSTM researchers among first to sequence snake genome
Researchers sequence genome for the king cobra
Researchers from LSTM, along with a team of international biologists who have recently sequenced the genome of the king cobra, say that their work reveals ...
Have researchers found a new treatment for sepsis?
2013-12-03
Have researchers found a new treatment for sepsis?
University of Leicester academics discover new receptor that may be instrumental in the body's response to devastating disease
Sepsis, or septicaemia, is a devastating disease that is difficult to diagnose early ...
Talk therapy may reverse biological changes in PTSD patients
2013-12-03
Talk therapy may reverse biological changes in PTSD patients
A study of biological markers of PTSD in Biological Psychiatry
Philadelphia, PA, December 3, 2013 – A new paper published in Biological Psychiatry suggests that cognitive behavioral therapy for posttraumatic ...
Citrus fruit inspires a new energy-absorbing metal structure
2013-12-03
Citrus fruit inspires a new energy-absorbing metal structure
Researchers use a naturally occurring structure to design aluminum materials
It has been said that nature provides us with everything that we need. A new study appearing in Springer's Journal of Materials Science ...
Researchers turn current sound-localization theories 'on their ear'
2013-12-03
Researchers turn current sound-localization theories 'on their ear'
Mass. Eye and Ear scientists challenge the two dominant theories of how people localize sounds
BOSTON (Dec. 3, 2013) – The ability to localize the source of sound is important for navigating ...
New thermoelectronic generator
2013-12-03
New thermoelectronic generator
Highly efficient new design, described in 'Journal of Renewable and Sustainable Energy,' converts heat and solar energy into electricity
WASHINGTON D.C. Dec. 3, 2013 -- Through a process known as thermionic conversion, heat ...
UK review examines gender differences in COPD patients
2013-12-03
UK review examines gender differences in COPD patients
LEXINGTON, Ky. (Dec. 3, 2013) — A new study review authored by the University of Kentucky's Dr. David Mannino examines the gender differences in the prevalence, pathophysiology, and clinical presentation of ...
Unlikely collaboration leads to discovery of 'gender-bending' plant
2013-12-03
Unlikely collaboration leads to discovery of 'gender-bending' plant
Bucknell professor Chris Martine never expected to be working with his mentor on identifying a new wild eggplant in Australia, especially since Martine's former colleague passed away years ago
Bucknell ...
Neurofeedback tunes key brain networks, improving subjective well-being in PTSD
2013-12-03
Neurofeedback tunes key brain networks, improving subjective well-being in PTSD
Pioneering research conducted at Western University (London, Canada) points to a promising avenue for the treatment of post-traumatic stress disorder (PTSD): utilising neurofeedback ...
LAST 30 PRESS RELEASES:
Do sweeteners increase your appetite? New evidence from randomised controlled trial says no
Women with obesity do not need to gain weight during pregnancy, new study suggests
Individuals with multiple sclerosis face substantially greater risk of hospitalisation and death from COVID-19, despite high rates of vaccination
Study shows obesity in childhood associated with a more than doubling of risk of developing multiple sclerosis in early adulthood
Rice Emerging Scholars Program receives $2.5M NSF grant to boost STEM education
Virtual rehabilitation provides benefits for stroke recovery
Generative AI develops potential new drugs for antibiotic-resistant bacteria
Biofuels could help island nations survive a global catastrophe, study suggests
NJIT research team discovering how fluids behave in nanopores with NSF grant
New study shows association of historical housing discrimination and shortfalls in colon cancer treatment
Social media use may help to empower plastic surgery patients
Q&A: How to train AI when you don't have enough data
Wayne State University researchers uncover potential treatment targets for Zika virus-related eye abnormalities
Discovering Van Gogh in the wild: scientists unveil a new gecko species
Small birds spice up the already diverse diet of spotted hyenas in Namibia
Imaging detects transient “hypoxic pockets” in the mouse brain
Dissolved organic matter could be used to track and improve the health of freshwaters
Indoor air quality standards in public buildings would boost health and economy, say international experts
Positive associations between premenstrual disorders and perinatal depression
New imaging method illuminates oxygen's journey in the brain
Researchers discover key gene for toxic alkaloid in barley
New approach to monitoring freshwater quality can identify sources of pollution, and predict their effects
Bidirectional link between premenstrual disorders and perinatal depression
Cell division quality control ‘stopwatch’ uncovered
Vaccine protects cattle from bovine tuberculosis, may eliminate disease
Andrew Siemion to receive the SETI Institute’s 2024 Drake Award
New study shows how the Crimean-Congo hemorrhagic fever virus enters our cells
Neoadjuvant chemotherapy proves effective for locally advanced penile squamous cell carcinoma
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
Doctors received approximately $12.1 billion from drug and device makers between 2013-2022
[Press-News.org] Tuberculosis: Nature has a double-duty antibiotic up her sleeveA natural antibiotic turns out to be a lethal weapon in the fight against tuberculosis. Scientists have discovered it has an unexpected dual action that dramatically reduces the probability that TB bacteria will become resistant